PL201, a Reported Rhamnoside Against Alzheimer's Disease Pathology, Alleviates Neuroinflammation and Stimulates Nrf2 Signaling. This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.